FRAMINGHAM, Mass. (AP) — FRAMINGHAM, Mass. (AP) — Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $689,000 in its second quarter.
On a per-share basis, the Framingham, Massachusetts-based company said it had a loss of 45 cents.
The company posted revenue of $589,900 in the period. Its adjusted revenue was $590,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XBIO at https://www.zacks.com/ap/XBIO
/AI%20(artificial%20intelligence)/Businessman%20touching%20the%20brain%20working%20of%20Artificial%20Intelligence%20(AI)%20Automation%20by%20Suttiphong%20Chandaeng%20via%20Shutterstock.jpg)
/Nvidia%20logo%20by%20Konstantin%20Savusia%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
